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Abstract 
Background: Percutaneous Coronary Intervention (PCI) is a common 
revascularisation technique. Serious complications are uncommon, but death is one 
of them. Seeking informed consent in advance of PCI is mandatory.  Research shows 
that PCI patients have inaccurate perceptions of risks, benefits, and alternative 
treatments. Aim: To assess cardiologists’ and patients’ views about the informed 
consent process and anticipated treatment benefits. Methods: Two cross-sectional, 
anonymous surveys were distributed in England. An electronic version to a sample of 
cardiologists, and a paper based version to patients recruited from 10 
centres.  Results: A sample of 118 cardiologists and 326 patients completed the 
surveys. Cardiologists and patients shared similar views on the purpose of informed 
consent; however, over 40% of patients and over a third of cardiologists agreed with 
statements that patients do not understand, or remember, the information given to 
them. Patients placed less value than cardiologists upon the consent process and over 
60% agreed that patients depended on their doctor to make the decision for them. 
Patients’ and cardiologists views on the benefits of PCI were significantly different; 
notably, 60% of patients mistakenly believed PCI was curative. Conclusions: The PCI 
informed consent process requires improvement to ensure that patients are more 
involved and accurately understand treatment benefits to make an informed decision. 
Redesign of the patient pathway is recommended to allow protected time for health 
professionals to engage in discussions using evidence based approaches such as 
‘teach back’ and decision support which improve patient comprehension. 
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Introduction 
Since its inception in the 1970’s Percutaneous Coronary Intervention (PCI), also 
known as coronary angioplasty with stenting, has evolved to become the most 
common invasive cardiovascular intervention performed in high and middle-income 
countries across the world.1 PCI, is the preferred treatment for people diagnosed with 
acute coronary syndrome, as it is associated with improved survival rates and a 
reduced incidence of death or non-fatal myocardial infarction (MI) when compared to 
medical therapy alone.2 However there is limited clinical evidence to suggest that PCI 
confers any survival benefit for those with stable coronary heart disease (CHD).3-5 
Therefore PCI is recommended in patients whose symptoms persist after the 
optimisation of medical therapy.6 Despite this guidance there has been an overuse of 
PCI in some countries. In America 10-12% of elective PCI procedures have been 
classified as being ‘inappropriate’, when matched with eligibility criteria listed in clinical 
guidelines, and a further 38% classified as having 'uncertain' approriateness.7-8 
Inappropriate PCI should be avoided as it can lead to avoidable patient harm as no 
medical procedure is free of risk. Health systems are mandated to make improvements 
to ensure that health care is safe and person centred;9 a high quality consent process 
exemplifies these characteristics.   
 
The combination of ‘inappropriate’ PCI’s with the policy imperative for shared decision-
making between patients and doctors has led to a renewed focus upon the consent 
process. As part of seeking consent for non-emergency PCI treatment, a patient and 
their cardiologist, will participate in a supported decision-making process which 
concludes with the signing of a consent document giving permission for treatment.  
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The informed consent process has the principle of patient autonomy at its foundation 
which means that individuals have the right to make decisions about what happens to 
them. Consent is required before any invasive medical or surgical procedure and for 
it to be valid, the patient must have the capacity to make a decision, be appropriately 
informed and act voluntarily.10 A key part of the PCI consent process involves a 
discussion in which the doctor discloses key information about what the procedure 
entails, the potential risks and benefits, alternative treatments and what would happen 
if they decided to have no treatment.10 The aim of such discussions is to make the 
patients aware that they have a choice to make about their treatment and options to 
consider within a supported decision making process. However the PCI informed 
consent process is complex because it is more than a simple information transfer. 
Rather, it is an interaction between two individuals, each with their own unique 
attitudes, values, preferences and expectations which influence what is said and how 
it is communicated.11  
International research reports that the amount and quality of the information given to 
patients undergoing PCI is variable; benefits are often overestimated, risks forgotten 
and alternative treatments not always considered.11-17  Effective risk communication is 
important as although elective and acute PCI are relatively low risk procedures  death 
is a complication in <1% of cases.18 Surprisingly patients are not always clear about 
the potential outcomes of PCI and often assume that elective PCI will prolong their 
lifespan and prevent a future MI; a view not always shared by their cardiologists.11 In 
summary PCI patients do not appear to be fully informed in the way that is described 
in clinical guidance.10 Therefore understanding the PCI informed consent process is 
an important step in identifying approaches to improve clinical practice which supports 
the rationale for this study.   
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There are no survey studies we are aware of reporting patients' and cardiologists' 
views about the informed consent process for coronary angioplasty in England. Our 
aim was to address this gap in current research by conducting a survey to assess 
cardiologists’ and patients’ views about the informed consent process and their 
understanding of anticipated treatment benefits.  
 
Methods 
Design 
Cross-sectional survey design.  
 
Study population and procedure 
A self-report questionnaire was distributed to two groups; a sample of 400 patients in 
England treated with either elective or acute PCI (acute/urgent cases but not primary 
PCI), and a non-probability sample of 400 UK cardiologists involved in taking PCI 
informed consent. The patient sample comprised participants recruited from a sample 
of 10 PCI centres in England, stratified by geographical region and PCI throughput 
(<400 or >400 PCI procedure per year). To reduce bias and support the 
generalisability of findings we randomly selected centres from each strata. Research 
nurses, not directly involved in the study, identified eligible patients. All adults 
undergoing elective or urgent PCI, who were able to read English, and willing to give 
their consent to particiate were included. Adults treated with primary PCI were 
excluded due to differences in the IC process.  
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The cardiologist sample was all 763 medically qualified British Cardiovascular 
Intervention Society (BCIS) members (64% consultants and 36% non-consultants) 
from a database held by a UK professional organisation; the total workforce of 
cardiologists in the UK is estimated to be 1400.19 Sample sizes were determined 
based on the primary aims of the study to determine the proportion of patients and 
cardiologists who identified key principles outlined in UK guidance10 as important and 
are comparable with other similar survey studies.16   
Instrument Development  
No validated surveys that matched the study aims were identified in a scoping review. 
Therefore  two researcher-generated questionnaires were designed (see Appendix 1), 
informed by items adapted from an existing survey.13  The two surveys were 
conceptually identical and focused upon participants’ views about informed consent 
(the purpose of informed consent, attitudes towards informed consent, and views 
about discussing treatment, risk, benefits and perceived outcomes). A 5-point Likert 
scale was completed, indicating the level of agreement with a total of 22 statements. 
Demographic data were also collected.The surveys were piloted and the content 
reviewed by clinicians (15 cardiologists and specialist nurses) and patients (5 patients 
diagnosed with CHD). Feedback was integrated into the final versions to support the 
acceptability and content validity of the measure. Lay terminology was used in the 
patient survey to maximise comprehension and the content was kept brief to minimise 
user fatigue and optimise response rates. Responses were scored 1 to 5 depending 
on the strength of agreement an individual have with a statement; a score of 1 
corresponding to ‘strongly agree’ and a score of 5 with strongly disagree. The items 
on the questionnaire were grouped into five distinct domains, each of which 
represented a specific outcome. For each group, a combined score for analysis was 
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created comprising the sum of all item scores in that group. All items were weighted 
equally within each group.   
Ethical considerations 
University ethical approval was secured before surveys were distributed, with 
additional approval from National Health Service Research Ethics Committee for the 
patient survey. The conduct of the study conformed with the ethical principles outlined 
in the Declaration of Helsinki.20 
Data collection 
The anonymous electronic questionnaire was distributed by email to all medically 
qualified members of the BCIS. Completion was indicative of participants consent. An 
E-survey was chosen as data is rapidly transmitted, responses are more likely to be 
candid and this approach matched participants computer literacy level. A paper-based 
patient survey was chosen to maximise patient participation. The questionnaire was 
administered by research nurses located at each of the participating National Health 
Service centres.   
Statistical Analysis 
Anonymised data from the electronic and paper-based questionnaires were extracted, 
inspected for invalid entries, obvious errors corrected and the extent of missing data 
assessed for suitability for imputation before coding of raw scores. A sample of data 
from the paper-based versions was double entered to support quality assurance. The 
demographic and health characteristics of the patient and cardiologist cohorts were 
summarised descriptively and Mann-Whitney U tests conducted to assess the 
significance (5% significance level) of any differences in responses between patients 
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and cardiologists, and/or between acute and elective patients. All analysis was 
conducted using SPSS statistical software (Version 24). 
Results 
Sample characteristics  
Tables 1 and 2 show the demographic data for the final sample of patients (n=326; 
82% response rate) and cardiologists (n=118; 16% response rate). The characteristics 
of the patients sample generally reflect those of the wider population diagnosed with 
CHD which supports the generalisability of findings. Almost one third of the sample 
(31%) needed some degree of help to understand health related written information. 
The majority of elective PCI patients (81%) were sent written information in advance 
and 99% signed their consent form on the day of their procedure. Forty-seven percent 
of all patients  would have liked a family member with them when their treatment was 
explained during the informed consent process.  
 The sample of cardiologists was predominantly male (92%). The average time to 
complete the consent process was between 6 to 9.5 minutes for low risk and high-risk 
patients respectively. Less than a quarter (23%) of operating cardiologists always 
conducted the consent processes for their patients.  
        
Table 1: here please (Summary of patient demographic, health and treatment 
characteristics)  
 
Elective and acute patients showed similar demographic and health-related 
characteristics.   
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Table 2: here please (Summary of cardiologist characteristics) 
  
Questionnaire data  
Survey data from patients (acute presentation (A) and elective presentation (E)) and 
cardiologists is presented separately.  
i. What is the purpose of informed consent? 
Patients: Almost all participants perceived informed consent to be a process that 
helped them to understand the benefits (91% A, 92 E), risks and complications (97% 
A 97% E) of PCI. The vast majority (89% A, 93% E)  agreed that informed consent 
was part of having the right to choose their treatment. Although numerically fewer, the 
majority also agreed that the purpose of the informed consent process was to educate 
them about alternative treatment options (72%A, 73% E).  
Cardiologists: Responding cardiologists reported that the main purpose of the PCI 
consent process was to provide information about benefits (95%), risks and 
complications (100%). The majority also  agreed that the process respected the right 
to autonomy (89%), and was an opportunity to discuss alternative treatments (71%).  
A Mann Whitney U test revealed no evidence at the 5% significance level for a 
difference between patients’ and cardiologists’ views of the purpose of informed 
consent (p=.050); mean patient rank =203.9, mean cardiologist rank=229.2).   
ii. Your attitude to informed consent  
Patients: A majority agreed that most patients depended on their doctor to make the 
decision for them (66% A, 62%).  
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Approximately half of respondents agreed that most patients do not usually 
understand (54% A, 41% E) or remember (67% A, 56%E) the information provided 
during the informed consent process.  
Cardiologists: Only approximately a quarter of cardiologists agreed that patients 
depended on their doctors to decide what is best for them (27%). A third agreed that 
most patients do not usually understand all of the information given to them during the 
IC process (34%), while around half (53%) agreed that most patients do not usually 
remember this information.  
A Mann Whitney U test revealed evidence at the 5% significance level for a  difference 
between  patients’ (acute and elective combined) and cardiologists’ views regarding 
the necessity and appropriateness of informed consent (p<.001; mean patient 
rank=191.6, mean cardiologist rank=270.1). Cardiologists considered informed 
consent to be more appropriate and necessary than patients.   
   
iii. Talking about my treatment and possible risks.  
Patients: Almost all patients agreed that they should have an explanation provided to 
them about what the PCI procedure entailed (98% A, 99% E), what the procedure 
aimed to achieve (98% A, 100% E), what additional procedures might be necessary 
(95% A, 97%), what other treatment options were available (80% A, 88% E) and what 
sort of realistic outcome they should expect (91% A, 94% E). (These items were 
grouped for analysis as being 'positive items'). The vast majority of patients, especially 
elective PCI patients, wanted to know about the possibility of death (78% A, 90% E), 
significant disability (84% A, 94% E), less significant disability (89% A, 95% E), 
alternative treatments (80%% A, 89% E), or what the outcome would be if they refused 
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treatment (80% A, 87% E). (These items were grouped for analysis as being 'negative 
items'). 
Cardiologists: All cardiologists agreed that the aim of PCI treatment be explained with 
procedural details and details about any risk of significant disability. Almost all 
cardiologists agreed that information about PCI outcomes should be explained (98%), 
the likelihood of additional future procedures (97%), the risk of less significant disability 
(94%), death as an outcome (93%), or the outcome if treatment was refused (90%). 
Over three quarters of the sample  agreed that alternative treatment options should be 
discussed (77%). 
A Mann-Whitney U test showed no evidence at the 5% significance level for a 
difference between  patients’ (acute and elective combined) and cardiologists’ views 
about the explanations of treatment and risk; either positive (p=.317;mean patient 
rank=208.4, mean cardiologist rank=221.1); or negative items (p=.570; mean patient 
rank=210.6, mean cardiologist rank=203.4).  
iv. Preferences about the charactersitics of risk information 
Patients: The vast majority of patients, especially elective PCI patients, wanted to 
know about all possible risks (86% A, 91% E). (For brevity these item was not included 
in the cardiologist survey). A Mann-Whitney U test showed no evidence at the 5% 
significance level for a difference in the views of acute and elective patients 
respectively (p=.717; mean elective patient rank=158.6, mean acute patient 
rank=158.6) about the disclosure of all possible risks linked to PCI.  
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v. What should I expect after PCI treatment? 
Patients: Almost all patients expected to have symptomatic relief (99% A, 98% E) with 
widened coronary arteries (99% A, 97% E). Over half (60% A, 60% E) believed that 
PCI would 'cure' their CHD. Most believed that PCI would reduce their risk of a future 
heart attack (89% A, 95% E) and increase their life span (87% A, 91% E).   
Cardiologists: The majority of cardiologists agreed that elective PCI would relieve 
symptoms (98%) and widen coronary arteries (88%). Few agreed that elective PCI  
was a cure for CHD, or would reduce future risk of AMI (12%) or prolong lifespan (3%).  
A Mann Whitney U test revealed evidence at the 5% significance level for a 
difference between the views of acute and elective patients about treatment 
expectations (p<.001; mean acute patient rank =275.1). Acute PCI patients had 
more accurate treatment expectations compared to elective PCI patients. 
 
Discussion 
Our study had two aims; to assess cardiologists’ and patients’ views about the 
informed consent process and their understanding of anticipated treatment benefits.  
To our knowledge this is the first study conducted in England to compare coronary 
angioplasty patients' and cardiologists' perspectives on the informed consent 
process. Patients and cardiologists shared remarkably similar views about the 
purpose of informed consent. Over 89% agreed that being informed, and able to act 
autonomously were key principles that underpinned the informed consent process. 
These views align with current guidance.10 However almost one third of patients and 
cardiologists disagreed that alternative treatments should be discussed in the 
informed consent process; a view that does not match current guidance.10 Knowing 
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about alternative treatment options is an important part of the patient being fully 
informed10 and is central to both person centred care21 and shared decision 
making.22 The lack of emphasis given to discussions about alternative treatments is 
reported in qualitative research about the patient experience of the informed consent 
process for both elective and acute coronary angioplasty procedures;11 findings 
showed that participants were typically unaware of alternative treatment options 
including the option of having no treatment.11 This general lack of awareness 
amongst patients about alternative treatment options is evident across other 
international survey studies which report that discussions about alternative 
treatments are not fully explored with patients scheduled for coronary 
revascularisation.23 This finding is also apparent in research focusing on non-cardiac 
elective procedures in which informed consent interactions tend to confirm a 
predetermined decision rather than facilitate supported decision-making.24 A 
preference to choose angioplasty as the first line treatment for stable coronary artery 
disease, rather than  medical therapy, has been reported elsewhere.25  
Patients' and cardiologists' attitudes about the necessity and appropriateness of the 
informed consent process for angioplasty were significantly different. Patients in this 
study placed less value, than cardiologists, on the consent process. Over half agreed 
that they depended on their doctor to decide what was best for them. A review of 
patients’ preferences for involvement in medical decision-making concluded that 
patients generally prefer a passive role, but preferences should be discussed on an 
individualised basis given the considerable variation that exists.26 Patients placing less 
value on the informed consent process may be because they do not perceive that they 
can offer a valid contribution. The perception of the doctor as the expert may be an 
obstacle to the greater engagement and involvement of patients in the PCI informed 
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consent process. The patient with heart disease is the ‘expert’ in living with their 
condition, but the doctor remains the ‘expert’ in knowing how to treat it. From a policy 
perspective there has been considerable discussion about the need to change the  to 
move from a ‘Doctor knows best’ viewpoint to ‘The patient in charge’ stance. However 
this is complex as it depends on the nature of the decision to be made, the context 
within which it occurs, the patients’ preference for involvement26. An important step is 
understanding the patients preference for involvement in the process at an early stage 
and assess this as regular intervals.27  
The process of supported decision making and the use of decision aids has the 
potential to promote greater patient involvement.28 Another approach to promote 
patient engagement may be greater involvement of family or friends. This study 
provides unique information about PCI patient preferences for involvement in informed 
consent discussions; almost half of the sample would have liked to have a family 
member or friend with them during the consent process.      
In our study, patients reported that they did not usually understand, or remember, the 
information given to them and, although less in number, many cardiologists shared the 
same view. Poor levels of patient comprehension and recall about the risks and 
benefits of PCI treatment has been reported in other international studies dating back 
over twenty years;11-17,23 our study adds an English perspective to these. There 
appears to have been limited progress in addressing this challenge, but the 
implementation of educational interventions and decision aids offers two approaches 
to improve patient knowledge and recall which will optimise the wider decision-making 
process that overlaps with the PCI informed consent. There is robust evidence to 
support the widespread adoption of both approaches. 28-29 Decision aids may be more 
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effective at encouraging patient participation in the decision making process and 
promoting accurate risk perceptions.30  
An inadequate level of health literacy is a major obstacle to patient participation in 
managing their own health care and is associated with poor health outcomes and  
increased health resource use which is costly both in patients suffering and scare 
economic resources.30 A large European survey reported that about one-third of 
patients have insufficient or problematic health literacy.31 A similar proportion of our 
study participants reported needing help to read health information. It is encouraging 
that 81% of elective participants received written health information ahead of PCI, but 
it seems likely that content needs redesign to make it more accessible to all. A recent 
study evaluated health information for heart failure and found that a high level of health 
literacy would be required to access, understand and act upon the 
recommendations.32  
We recommend the streamlining of PCI health information (e.g. Patient Information 
Leaflets) with the co-creation and re-design of core content for a PCI patient curriculum 
that can be used across hospitals.  This would support consistency in health 
information resources across health settings. Content would be designed and 
simplified to ensure that health literacy demand would meet the needs of service-
users. We also suggest that mapping the PCI patient pathway, which will vary by 
institution, to enable health professionals to identify potential therapeutic educational 
‘contact points’. In this way ‘chunks’ of the patient curriculum can be staged across 
health professional-patient contact points to avoid information overload. Most 
importantly the health information should explicitly invite the patient to take part in the 
supported decision-making process, within which the angioplasty informed consent 
process is embedded, and emphasise the value of their full participation. This is 
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important because patient awareness of ‘choice’ is the first step of the supported 
decision making process.22 Research indicates that more often than not PCI patients 
do not fully understand that they have a choice which contributes to them adopting a 
passive role.11  
PCI patients' and cardiologists' shared similar views about which aspects of treatment 
and risks should be explained to patients as part of the informed consent process. The 
majority wanted to both give, and receive, detailed information about the possibility of 
death, and complications, both significant and less significant. Legislative frameworks 
concerning informed consent will vary by country but the changes in the law in England 
following the ruling in Montgomery33 requires doctors to ensure patients are aware of 
any ‘material’ risks associated with treatment and to discuss alternatives. The doctor 
must decide what a ‘reasonable person’ in the patients position would want to know 
about the potential risks, no matter how infrequent. The key role of the health 
professional is to ensure that information is presented in a meaningful way.34 The 
consent process involves discussions which happen over several episodes of care 
often with different health professionals which means that the process can be 
disjointed. We recommend a reconfiguration and standardisation of the PCI patient 
pathway that allows the doctor, patient, and those close to them, the necessary time 
to develop a therapeutic relationship. An absence of protected time has been identified 
as an obstacle to a quality consent process for surgeons35 and we belive that this also 
applies in the field of interventional cardiology.  
The majority of PCI patients wanted to know about all possible risks and there was no 
difference in the views and preferences of those who had experienced either acute or 
elective treatment. Risk communication is an important part of information disclosure 
which occurs within medical-decision making and as part of a valid informed consent 
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process. Cardiologists need to be supported to enable them to strengthen their skills 
in communicating risk using effective techniques such as ‘teach-back’ with the 
incorporation of decision support.36-37  This is important as the way that risk is 
presented and discussed influences patients’ perceptions of their personal risk.36 
An accurate understanding of the benefits of PCI is a requirement of a valid consent 
process. The majority of acute and elective PCI patients shared the view that PCI 
would relieve symptoms. However over half of the sample perceived that PCI would 
‘cure’ their heart disease. Studies published twenty years ago have reported that 
elective PCI patients see their treatment as a ‘cure’,38 and little seems to have 
changed.39 Acute PCI patients had significantly different views about treatment 
expectations, which were more accurate than the views of those treated with elective 
PCI. Most elective PCI patients believed that their treatment would reduce their risk of 
a future heart attack and increase their lifespan: beliefs that do not reflect clinical 
guidelines.6 It is not clear why this difference exists. The elective PCI patient pathway 
allows more time for explanation and deliberation but this appears to have no effect 
on the way patients interpret the benefits of PCI. This is an important and orginal 
finding which warrants further consideration. We recommend that future research 
should identify interventions designed to correct this misconception within a revised 
informed consent discussion which is the final step in a suported decision making 
process. A clause on the consent form could be added that explains that PCI is not 
curative but that secondary prevention offers patients a way to control disease 
progression. 
All studies have limitations and whilst findings from the patient sample are likely to be 
generalisable given the study design and excellent response rate, the cardiologist 
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sample is more likely to be subject to non-response bias so must be interpreted with 
this in mind.   
The importance of a robust informed consent process has been given renewed focus 
as a marker of high quality cardiology care.40 Moreover UK policy, which sets out the 
principles of good practice in the informed consent process for doctors, is being 
updated.41 Findings from this study, and others,11 have identified that the informed 
consent process requires improvement and key learning from this research has 
helped to shape the update of UK policy. The renewed emphasis on supported 
decision making reflects a paradigm shift in thinking about the informed consent 
process with the patients’ views and preferences becoming more prominent. This 
reframing of patient-health professional discussions will no doubt gather momentum 
across other international health settings but requires the reconfiguration of the PCI 
patient pathway.   
Conclusion  
The PCI informed consent process requires improvement to ensure that patients are 
more involved and accurately understand treatment benefits to make an informed 
decision. Redesign of the patient pathway is recommended to allow protected time for 
health professionals to engage in discussions with patients, and those close to them, 
using evidence based approaches such as ‘teach back’ and decision support to 
improve patient comprehension.   
Implications for practice  
• Patients need to understand fully their role in the angioplasty consent process and 
need encouragement to participate in it from start to finish with those close to them.  
  
19 
 
• Patient health information needs to be co-created by patients and health 
professionals to reduce health literacy demand and support recall and comprehension.  
• Most patients want to know about all of the potential risks of coronary angioplasty 
but overestimate the benefits of angioplasty and perceive it as a cure.  
• Cardiologists require training in the use of decision support, communication and 
patient engagement skills such as ‘teach back’ to ensure angioplasty patients are fully 
informed.  
• There is a gap between consent policy and clinical practice that could be addressed 
through service reconfiguration, skills training for health professionals and the re-
design of health information resources. 
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Table 1: Summary of patient demographic, health and treatment characteristics  
 
Variable Acute 
patients 
Elective 
patients 
All patients 
Age (years) (mean (SD)) 66.2 (12.2) 66.8 (11.8) 66.5 (12.0) 
Gender 
   Male 
   Female 
 
118 (74.2%) 
41 (25.8%) 
 
127 (76.0%) 
40 (24.0%) 
 
245 (75.2%) 
81 (24.8%) 
Employment status 
   Full-time employment 
   Part-time employment 
   Retired 
   Unemployed 
   Other 
 
35 (22.3%) 
11 (7.0%) 
86 (54.8%) 
8 (5.1%) 
17 (10.9%) 
 
27 (16.5%) 
6 (3.7%) 
100 (61.0%) 
9 (5.5%) 
22 (13.4%) 
 
62 (19.0%) 
17 (5.2%) 
186 (57.1%) 
17 (5.2%) 
39 (12.2%) 
Help needed with written medical 
information 
   Never 
   Rarely 
   Sometimes 
   Often 
   Always 
 
 
101 (63.9%) 
23 (14.6%) 
18 (11.4%) 
10 (6.3%) 
6 (3.8%) 
 
 
121 (74.2%) 
15 (9.2%) 
19 (11.7%) 
1 (0.6%) 
7 (4.3%) 
 
 
222 (69.2%) 
38 (11.8%) 
37 (11.5%) 
11 (3.4%) 
13 (4.0%) 
Frequency of chest pains in last 4 weeks 
   None 
 
34 (21.9%) 
 
34 (21.1%) 
 
68 (21.5%) 
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   Less than 1 per week 
   1-2 per week 
   3 or more per week 
   1-3 per day 
   4 or more per day 
30 (19.4%) 
24 (15.5%) 
26 (16.8%) 
25 (16.1%) 
16 (10.3%) 
25 (15.5%) 
30 (18.6%) 
33 (20.5%) 
26 (16.1%) 
13 (8.1%) 
55 (17.4%) 
54 (17.1%) 
59 (18.7%) 
51 (16.1%) 
29 (9.2%) 
*(frequency and valid percentages given except where indicated) 
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Table 2: Summary of cardiologist characteristics  
 
Variable Frequency (valid %) 
Gender 
   Male 
   Female 
 
108 (91.5%) 
10 (8.5%) 
Position 
   Consultant Cardiologist (Interventionalist) 
   Consultant Cardiologist (Non-Interventionalist) 
   Specialist Registrar/Fellow 
   Other 
 
98 (83.1%) 
1 (0.8%) 
17 (14.4%) 
2 (1.7%) 
Workplace 
   Regional tertiary cardiac centre, on-site cardiac surgery 
   Non-surgical tertiary PCI centre 
   Stand-alone, non-surgical PCI centre 
 
61 (51.7%) 
23 (19.5%) 
34 (28.8%) 
Frequency of PCI consent interactions per month 
   None 
   1-25 times 
   26-50 times 
   51-75 times 
   Over 75 times 
 
1 (0.8%) 
84 (67.7%) 
30 (24.2%) 
8 (6.5%) 
1 (0.8%) 
Frequency of operator conducting informed consent discussions  
for PCI procedures performed 
 
 
  
30 
 
   Always (100%) 
   Mostly (75%) 
   Usually (50%) 
   Sometimes (25%) 
29 (23.4%) 
45 (36.3%) 
20 (16.1%) 
30 (24.2%) 
Annual volume of PCI procedures at centre 
   200-400 
   400-1000 
   1000-2000 
   Over 2000 
 
14 (11.9%) 
41 (34.7%) 
47 (39.8%) 
16 (13.6%) 
*(frequency and valid percentages given except where indicate  
